Your Location:
Home >
Browse articles >
Role of Cytokines and Related Signaling Pathways in Intervention of Chinese Medicine in Radiation-induced Lung Injury: A Review
Updated:2023-10-20
    • Role of Cytokines and Related Signaling Pathways in Intervention of Chinese Medicine in Radiation-induced Lung Injury: A Review

      Enhanced Publication
    • SHAO Jiayi , WU Mianhua , MA Yanxia , JIANG Zequn , XU Hongyi , LI Muhan
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 22, Pages: 244-253(2023)
    • DOI: 10.13422/j.cnki.syfjx.20222425     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

191

Views

579

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Chinese Medicine against Parkinson's Disease Based on Microbiota-Gut-Brain Axis Theory: A Review
Dabupi Tang Ameliorates Radiation-induced Lung Injury by Regulating Inflammation via JAK1/STAT6 Signaling Pathway
Jiebiao Qingli Decoction Regulates TLR7/MAPK/NF-κB Pathway to Prevent and Treat Pneumonia Induced by IAV Infection
Regulatory Mechanism of Radiation Therapy for Lung Cancer with Traditional Chinese Medicine: A Review
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway

Related Author

GAO Xin
LIU Chen
TONG Dapeng
LIU Shumin
ZHANG Chaoning
LAN Yu
WU Zhengjuan
YU Chenzu

Related Institution

Heilongjiang University of Chinese Medicine
Heilongjiang Shenzhi Hospital
Gansu University of Chinese Medicine
Clinical Research Center for Respiratory Diseases,China-Japan Friendship Hospital
Beijing Oriental Yunjia Pharmaceuticals Co. Ltd.